Improving access to generic drugs through a tiered-pricing framework
A new investigation from the CHÉOS Health Economics Program indicates the framework could speed up generic entry to Canadian public health plans
Read MoreA new investigation from the CHÉOS Health Economics Program indicates the framework could speed up generic entry to Canadian public health plans
Read MoreNew research from the CHÉOS Health Economics Program finds market factors and pricing policies may be to blame
Read MoreCHÉOS Scientists are testing the cost-effectiveness of a new blood test that aims to avoid the unnecessary health complications and costs of current methods
Read MoreCHÉOS researchers address unanswered questions to guide policy and resource allocation for chronic disease management
Read MoreCHÉOS Scientists Dr. Aslam Anis and Dr. Wei Zhang conducted a cost-effectiveness analysis comparing three Down syndrome screening techniques, published this week in PLoS One
Read MoreDr. Linda Li leads a series of studies that integrate Fitbit technology with physiotherapist counselling to improve exercise habits in people living with arthritis
Read More